AN2 Therapeutics (ANTX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ANTX AN2 Therapeutics

Watchlist

1.370
-0.020-1.44%

Close Nov 27 16:00 ET

1.470
+0.100+7.30%

Pre 09:13 ET

40.93MMarket Cap-688P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Recursion Pharmaceuticals (RXRX) and AN2 Therapeutics, Inc. (ANTX)
TipRanksNov 25 01:00 ET · Ratings
Insider Spends US$213k Buying More Shares In AN2 Therapeutics
Simply Wall StNov 23 07:55 ET
Insider Purchase: Director at $ANTX (ANTX) Buys 5,000 Shares
Quiver QuantitativeNov 20 16:20 ET
Kevin Krause Named President and CEO of ArrePath
BusinesswireNov 19 08:15 ET
JMP Securities Maintains AN2 Therapeutics(ANTX.US) With Buy Rating, Maintains Target Price $5
Moomoo NewsNov 19 03:36 ET · Ratings
TD Cowen Initiates AN2 Therapeutics(ANTX.US) With Hold Rating
Moomoo NewsNov 19 03:36 ET · Ratings

Comments

This_Guy

2 minutes ago

$AN2 Therapeutics (ANTX.US)$
I am in here for swing play. Chart looks good and insiders have been loading.

Trytosaveabit

Oct 17 06:03

Update

$AN2 Therapeutics (ANTX.US)$ Reuters· 1 min ago
AN2 Therapeutics Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis (Caused by Mycobacterium Tuberculosis) and Malaria

Dps

Sep 24 16:00

$AN2 Therapeutics (ANTX.US)$ any future for this or it will float between 1.04 and 1.07

Trytosaveabit

Aug 12 15:54

Hmm

$AN2 Therapeutics (ANTX.US)$ Bml Investment Partners, L.p. Reports 14.2% Passive Stake in AN2 Therapeutics as of August 9, 2024- SEC Filing

MARKET-TEST-DUMMY

Aug 11 20:49

👁

$AN2 Therapeutics (ANTX.US)$

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

ANTX AN2 Therapeutics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target